Compile Data Set for Download or QSAR
maximum 50k data
Found 41 Enz. Inhib. hit(s) with all data for entry = 9439
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391980(Ethyl 3-{2-[1-({[4- (trifluoromethyl)phenyl] carba...)
Affinity DataEC50:  1.11E+3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391979(Ethyl 3-[2-(1-{[(4- Bromophenyl)carbamoyl] amino}e...)
Affinity DataEC50:  734nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391982(US10301269, Number 27 | US10800744, Number 27 | {2...)
Affinity DataEC50:  46nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391983(1-[(1S)-1-(1H-imidazol- 2-yl)-2-methylpropyl]- 3-[...)
Affinity DataEC50:  4nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391984(1-(4-Chlorophenyl)-3- [(1S)-1-(1H-imidazol-2- yl)-...)
Affinity DataEC50:  9nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391985(1-(4-Bromo-2- fluorophenyl)-3-[(1S)-1- (1H-imidazo...)
Affinity DataEC50:  8nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391986(1-[(1S)-1-(1H-imidazol- 2-yl)-2-methylpropyl]- 3-(...)
Affinity DataEC50:  109nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391987(US10301269, Number 33 | US10800744, Number 33 | te...)
Affinity DataEC50:  361nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391988(US10301269, Number 34 | US10800744, Number 34 | te...)
Affinity DataEC50:  855nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391989(US10301269, Number 35 | US10800744, Number 35 | te...)
Affinity DataEC50:  139nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391990((2-{(1S)-2-Methyl-1- [({[4- (trifluoromethyl)pheny...)
Affinity DataEC50:  3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391991(US10301269, Number 37 | US10800744, Number 37 | {2...)
Affinity DataEC50:  40nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391992(US10301269, Number 38 | US10800744, Number 38 | {2...)
Affinity DataEC50:  14nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391993(US10301269, Number 39 | US10800744, Number 39 | {2...)
Affinity DataEC50:  106nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391994(2-(2-{(1S)-2-methyl-1- [({[4-(trifluoromethyl) phe...)
Affinity DataEC50:  43nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391995(2-(2-{(1S)-2-methyl-1- [({[4-(trifluoromethyl) phe...)
Affinity DataEC50:  206nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391996(N,N-Dimethyl-2-(2- {(1S)-2-methyl-1-[({[4- (triflu...)
Affinity DataEC50:  277nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391956(1-(4-Bromophenyl)-3- [1-(1H-imidazol-2- yl)propyl]...)
Affinity DataEC50:  898nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391957(1-(4-Bromophenyl)-3- [(1S)-1-(1H-imidazol-2- yl)bu...)
Affinity DataEC50:  2.07E+3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391958(1-(4-Bromophenyl)-3- [(1S)-1-(1H-imidazol-2- yl)-2...)
Affinity DataEC50:  46nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391959(1-(4-Bromophenyl)-3- (1H-imidazol-2- ylmethyl)urea...)
Affinity DataEC50:  175nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391960(1-(4-Bromophenyl)-3- [1-(1H-imidazol-2- yl)ethyl]u...)
Affinity DataEC50:  401nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391961(1-[1-(1H-Imidazol-2- yl)propyl]-3-[4- (trifluorome...)
Affinity DataEC50:  199nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391962(Ethyl [2-(1-{[(4- Bromophenyl)carbamoyl] amino}pro...)
Affinity DataEC50:  439nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391963(Ethyl {2-[(1S)-1-{[(4- bromophenyl)carbamoyl] amin...)
Affinity DataEC50:  1.09E+3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391964(US10301269, Number 9 | US10800744, Number 9 | tert...)
Affinity DataEC50:  1.29E+3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391965(US10301269, Number 10 | US10800744, Number 10 | te...)
Affinity DataEC50:  1.11E+3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391966(Ethyl [2-({[(4- Bromophenyl)carbamoyl] amino}methy...)
Affinity DataEC50:  400nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391967(Ethyl [2-(1-{[(4- Bromophenyl)carbamoyl] amino}eth...)
Affinity DataEC50: >2.00E+3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391968(1-(4-Bromophenyl)-3- {1-[1-(2-hydroxyethyl)- 1H-im...)
Affinity DataEC50:  200nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391969(Ethyl 2-[2-({[(4- Bromophenyl)carbamoyl] amino}met...)
Affinity DataEC50:  584nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391970(Ethyl {2-[1-({[4- (trifluoromethyl)phenyl] carbamo...)
Affinity DataEC50:  332nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391971(US10301269, Number 16 | US10800744, Number 16 | [2...)
Affinity DataEC50:  47nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391972(US10301269, Number 17 | US10800744, Number 17 | [2...)
Affinity DataEC50:  3.28E+3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391973(US10301269, Number 18 | US10800744, Number 18 | [2...)
Affinity DataEC50:  30nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391974(2-[2-({[(4- Bromophenyl)carbamoyl] amino}methyl)-1...)
Affinity DataEC50:  270nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391975(3-[2-(1-{[(4- Bromophenyl)carbamoyl] amino}propyl)...)
Affinity DataEC50:  42nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391976(US10301269, Number 21 | US10800744, Number 21 | {2...)
Affinity DataEC50:  6.60nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391977(3-{2-[1-({[4- (Trifluoromethyl)phenyl] carbamoyl}a...)
Affinity DataEC50:  23nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391978(Ethyl 3-[2-(1-{[(4- Bromophenyl)carbamoyl] amino}p...)
Affinity DataEC50:  1.21E+3nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN-formyl peptide receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM391981(US10301269, Number 26 | US10800744, Number 26 | {2...)
Affinity DataEC50:  173nMAssay Description:Biological activity of compounds according to Formula I is set forth in Table 7 below. CHO-Gα16 cells stably expressing FPR2 were cultured in (F...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent